Anavex Life Sciences Corp (AVXL)

[Drano]

"They" ("They" being the Wall Street Insiders who came up with the AXON scam) will try to create excitement around their one and only drug, the previously shelved (disappointing) drug they bought for a measly 5 million from the company that concluded that it was not worth developing. They will announce human trials in September, right as (what a coincidence) the 90 day lock-up period expires, which has prevented insiders from selling their stock when it was at 31 on IPO day 4 weeks ago, and which has been as low as 17 since then. So, the stock will run up, the insiders will sell, then people will discover that **gasp** the drug doesn't work well enough to be approved, and AXON goes to zero.

But the insiders will be very, very, very rich.

By contrast, CTI* paid 5 million to get the intellectual property to a whole new class of antibiotics. Its market cap is a small fraction of AXON's, despite having at least 4 clinical trials going on. Efficient market theory, bah humbug!